GHS-R1a signaling drives anxiety-related behavior by shaping excitability of ventromedial hypothalamic neurons.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40274845.
- Also identified by DOI 10.1038/s41467-025-59116-3 and PMC identifier 12022087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The neural substrates of anxiety are poorly understood, which hinders treatment of anxiety disorders. Here we found, αCaMKII<sup>+</sup> neurons in the ventral medial hypothalamic nucleus (VMH) responded to stressors with increased activity in male mice, both under physiological conditions and after repeated restraint stress. Activation of VMH αCaMKII<sup>+</sup> neurons were necessary and sufficient to ameliorate stress-induced anxiety. The peripheral metabolic hormone ghrelin and receptor GHS-R1a play a complex role in emotion regulation; however, the mechanism is uncertain. A delayed increase in GHS-R1a expression in VMH αCaMKII<sup>+</sup> neurons coincided with the development of stress-induced enhancement of anxiety-related behavior. GHS-R1a expression in VMH αCaMKII<sup>+</sup> neurons promoted anxiety-related behavior, whereas GHS-R1a knockdown had the opposite effect. GHS-R1a upregulation inhibited the excitability of VMH αCaMKII<sup>+</sup> neurons. We conclude that GHSR1a signaling drives stress-induced anxiety by shaping the activity of VMH αCaMKII<sup>+</sup> neurons. GHS-R1a may be a therapeutic target for treating anxiety disorders such as post-traumatic stress disorder.
Medical subject headings
- Neurons
- Anxiety
- Receptors, Ghrelin
- Ventromedial Hypothalamic Nucleus